Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Mbio|February 22, 2024
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaquesNatasha S Kelkar, Benjamin S Goldberg, Jérémy Dufloo, et al.Cell Host & Microbe|December 4, 2014
IFITM proteins incorporated into HIV-1 virions impair viral fusion and spreadAlex A Compton, Timothée Bruel, Françoise Porrot, et al.Veterinary Immunology and Immunopathology|February 3, 2012
Porcine colon explants in the study of innate immune response to Entamoeba histolyticaFabienne Girard-Misguich, Mario Delgado-Ortega, Patricia Berthon, et al.Mbio|October 12, 2021
Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 ActivityBenjamin S Goldberg, Chengzi I Kaku, Jérémy Dufloo, et al.Journal of Virology|January 27, 2017
Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 AntibodiesTimothée Bruel, Florence Guivel-Benhassine, Valérie Lorin, et al.ACS Omega|November 6, 2023
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral ActivityThane Jones, Natalia Monakhova, Florence Guivel-Benhassine, et al.Journal of Virology|December 20, 2019
Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5Isabelle Staropoli, Jérémy Dufloo, Anaïs Ducher, et al.Nature Communications|February 3, 2022
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cellsJérémy Dufloo, Cyril Planchais, Stéphane Frémont, et al.EMBO Reports|December 14, 2019
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cellsJérémy Dufloo, Florence Guivel-Benhassine, Julian Buchrieser, et al.European Journal of Immunology|August 28, 2022
IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodiesLudivine Grzelak, Ferdinand Roesch, Amaury Vaysse, et al.Pageof 10